Evidence map›Paper›PMID 39744248›Full record

ArticleCureus2024

Unclassifiable Renal Cell Carcinoma With an Estimated 100% Sarcomatoid Component: A Case Report.

Chaimae Bekhakh, Anass Haloui, Nada Akouh, Karich Nassira, Amal Bennani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chaimae BekhakhDepartment of Anatomopathology, Mohammed VI University Hospital/Faculty of Medicine, Mohammed 1st University, Oujda, MAR.
Anass HalouiDepartment of Anatomopathology, Mohammed VI University Hospital/Faculty of Medicine, Mohammed 1st University, Oujda, MAR.
Nada AkouhDepartment of Anatomopathology, Mohammed VI University Hospital/Faculty of Medicine, Mohammed 1st University, Oujda, MAR.
Karich NassiraDepartment of Anatomopathology, Mohammed VI University Hospital/Faculty of Medicine, Mohammed 1st University, Oujda, MAR.
Amal BennaniDepartment of Anatomopathology, Mohammed VI University Hospital/Faculty of Medicine, Mohammed 1st University, Oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomatoid renal cell carcinoma (RCC) is an aggressive tumour with a poor prognosis. It is not a distinct histological entity, as it can be found in any subtype of renal cell carcinoma. The majority of cases will present with advanced or metastatic disease requiring systemic treatment. However, pathologists are sometimes confronted with renal cell tumours that do not fit any definition, so these tumours must be considered unclassified renal cell carcinomas. The criteria for this classification are varied and include tumours with more than one histological subtype, tumours with unrecognized epithelial histological subtypes, mucin-producing tumours, and tumours with an exclusively sarcomatoid or rhabdoid morphology. The latter subgroup of unclassified renal cell carcinomas is rare in renal pathology. Consequently, the presence and quantity of the sarcomatoid component must be reflected in pathology reports. We report the case of a 76-year-old male patient presenting with intermittent left lumbar pain for two months, in a deteriorating general condition. Histological and immunohistochemical examinations revealed an unclassifiable renal cell carcinoma with an estimated 100% sarcomatoid component.

Indexed as

carcinomakidneyrare entitysarcomatoidunclassifiable

Identifiers

PMID39744248
PMCPMC11692686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.